The Epigenetic Machinery in Vascular Dysfunction and Hypertension

Area of Science:

• Cardiovascular Science
• Genetics and Epigenetics

Background:

• Hypertension (HT) is a major component of metabolic syndrome, posing significant global health risks for cardiovascular disease, morbidity, and mortality.
• Despite its prevalence, the multifactorial pathogenesis of HT remains largely unknown, necessitating deeper mechanistic insights for effective intervention.
• Addressing the global burden of HT, including 9.4 million annual deaths, requires identifying novel therapeutic targets.

Purpose of the Study:

• To provide a critical update on epigenetic modifications in genes linked to elevated blood pressure.
• To review the role of microRNAs (miRNAs) in regulating gene expression relevant to HT.
• To explore the impact of fetal programming on adult susceptibility to hypertension.

Main Methods:

• Literature review of epigenetic modifications in hypertension pathways.
• Focus on genes involved in vascular epithelium regulation.
• Analysis of microRNA's role in gene expression and fetal programming related to HT.

Main Results:

• Epigenetic modifications are increasingly recognized in the development of complex diseases like HT.
• Specific epigenetic mechanisms, particularly involving the vascular epithelium, are implicated in elevated blood pressure.
• MicroRNAs play a significant role in regulating genes associated with hypertension and may mediate developmental susceptibility.

Conclusions:

• Epigenetic factors, including miRNAs and fetal programming, are critical in hypertension pathogenesis.
• Further research into these epigenetic mechanisms is essential for developing innovative therapeutic strategies.
• Understanding epigenetic regulation offers a promising avenue for reducing the global burden of hypertension.